Quick Answer
IONIS PHARMACEUTICALS INC reported Net Income Loss of -$381.39 million for the year ending 2025.
- IONIS PHARMACEUTICALS INC showed an increase of +16.0% in Net Income Loss from 2024 to 2025.
- This data is from IONIS PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2008 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2008 to 2025), IONIS PHARMACEUTICALS INC's Net Income Loss has declined by 1,998.8%.
- Historical annual values: Fiscal year 2025: -$381.39 million | Fiscal year 2024: -$453.90 million | Fiscal year 2023: -$366.29 million | Fiscal year 2022: -$269.72 million | Fiscal year 2021: -$28.60 million | Fiscal year 2020: -$444.26 million | Fiscal year 2019: $278.14 million | Fiscal year 2018: $273.74 million | Fiscal year 2017: $346.0 thousand | Fiscal year 2016: -$60.40 million | Fiscal year 2015: -$88.28 million | Fiscal year 2014: -$38.98 million | Fiscal year 2013: -$60.64 million | Fiscal year 2010: -$61.25 million | Fiscal year 2009: $155.07 million | Fiscal year 2008: -$18.17 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: